华绿生物(300970)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300970 华绿生物

已收盘 02-06 15:00:00

{"stockData":{"symbol":"300970","market":"SZ","secType":"STK","nameCN":"华绿生物","latestPrice":23.2,"timestamp":1770361428000,"preClose":22.4,"halted":0,"volume":5776200,"delay":0,"changeRate":0.0357,"floatShares":95136100,"shares":123000000,"eps":0.0315,"marketStatus":"已收盘","change":0.8,"latestTime":"02-06 15:00:00","open":22.31,"high":23.88,"low":22.19,"amount":133000000,"amplitude":0.0754,"askPrice":23.2,"askSize":54,"bidPrice":23.19,"bidSize":142,"shortable":0,"etf":0,"ttmEps":0.0315,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":22.4,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":24.64,"lowLimit":20.16,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":122609100,"isCdr":false,"pbRate":1.79,"roa":"--","peRate":736.507937,"roe":"1.08%","epsLYR":-0.41,"committee":0.556634,"marketValue":2845000000,"turnoverRate":0.0607,"status":0,"floatMarketCap":2207000000},"requestUrl":"/m/hq/s/300970","defaultTab":"news","newsList":[{"id":"2608894926","title":"股市必读：华绿生物（300970）2月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608894926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608894926?lang=zh_cn&edition=full","pubTime":"2026-02-03 02:50","pubTimestamp":1770058219,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，华绿生物报收于21.66元，下跌7.16%，换手率9.13%，成交量8.68万手，成交额1.91亿元。公司目前鲜品灰树花的日产能约为6吨，公司是上市公司中唯一一家实现工厂化种植的企业。目前公司灰树花主要以鲜品销售为主。当日关注点来自交易信息汇总：2月2日主力资金净流出135.12万元，游资资金净流出350.75万元，散户资金净流入485.87万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2608851093","title":"2月2日华绿生物跌7.16%，华泰柏瑞量化阿尔法A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608851093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608851093?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:56","pubTimestamp":1770022589,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日华绿生物跌7.16%，收盘报21.66元，换手率9.13%，成交量8.68万手，成交额1.91亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞量化阿尔法A。华泰柏瑞量化阿尔法A目前规模为2.93亿元，最新净值1.951，较上一交易日上涨1.31%，近一年上涨40.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2608858018","title":"华绿生物：公司目前鲜品灰树花的日产能约为6吨","url":"https://stock-news.laohu8.com/highlight/detail?id=2608858018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608858018?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:04","pubTimestamp":1770015859,"startTime":"0","endTime":"0","summary":"公司目前鲜品灰树花的日产能约为6吨，公司是上市公司中唯一一家实现工厂化种植的企业。灰树花是食、药兼用菌，子实体肉质，柄短呈珊瑚状分枝，重叠成丛，其外观婀娜多姿、层叠似菊；其气味清香四溢，沁人心脾；其肉质脆嫩爽口、百吃不厌，具有很好的保健作用和很高的药用价值。目前公司灰树花主要以鲜品销售为主。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200015098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2607090957","title":"1月30日华绿生物涨7.02%，华泰柏瑞量化阿尔法A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607090957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607090957?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:43","pubTimestamp":1769762610,"startTime":"0","endTime":"0","summary":"证券之星消息，1月30日华绿生物涨7.02%，收盘报23.33元，换手率11.73%，成交量11.16万手，成交额2.55亿元。重仓华绿生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞量化阿尔法A。华泰柏瑞量化阿尔法A目前规模为2.93亿元，最新净值1.9258，较上一交易日下跌0.51%，近一年上涨38.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2604193859","title":"华绿生物(300970.SZ)发预盈，预计2025年归母净利润1亿元至1.3亿元，扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2604193859","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604193859?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:34","pubTimestamp":1768898094,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华绿生物(300970.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润1亿元至1.3亿元，扭亏为盈;归属于上市公司股东扣除非经常性损益后的净利润1亿元至1.3亿元。公司业绩的提升主要得益于销售单价与销售量的同步增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"华绿生物(300970.SZ)发预盈，预计2025年归母净利润1亿元至1.3亿元，扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300970"],"gpt_icon":0},{"id":"2601356453","title":"1月8日华绿生物涨5.53%，华泰柏瑞量化阿尔法A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356453","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356453?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:41","pubTimestamp":1767858066,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日华绿生物涨5.53%，收盘报20.62元，换手率9.09%，成交量8.65万手，成交额1.75亿元。重仓华绿生物的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞量化阿尔法A。华泰柏瑞量化阿尔法A目前规模为2.03亿元，最新净值1.7844，较上一交易日下跌0.56%，近一年上涨31.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2595192057","title":"股市必读：华绿生物（300970）12月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2595192057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595192057?lang=zh_cn&edition=full","pubTime":"2025-12-31 01:37","pubTimestamp":1767116229,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，华绿生物报收于21.56元，上涨4.81%，换手率20.5%，成交量19.5万手，成交额4.25亿元。董秘最新回复投资者： 2025年12月13日9时8分，蓬溪骆峰菌业黄色金针菇及金钱菌干品，随紫微科技自主研发的迪迩五号·中国科技城号空间试验器，由快舟十一号运载火箭从酒泉卫星发射中心成功送入近地轨道。当日关注点来自交易信息汇总：12月30日主力资金净流出2795.34万元，显示主力资金呈明显离场态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100001381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2595767103","title":"华绿生物：持续强化核心技术研发与积累","url":"https://stock-news.laohu8.com/highlight/detail?id=2595767103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595767103?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:09","pubTimestamp":1767082150,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物12月30日在投资者关系平台上答复投资者关心的问题。公司始终紧密追踪行业发展趋势，并持续强化核心技术的研发与积累。在此基础上，公司聚焦主营业务，通过持续创新不断提升核心竞争力，为股东创造长期、稳定的投资回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000022607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2595207285","title":"12月29日华绿生物涨6.86%，华泰柏瑞量化阿尔法A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595207285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595207285?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:38","pubTimestamp":1766993913,"startTime":"0","endTime":"0","summary":"证券之星消息，12月29日华绿生物涨6.86%创60日新高，收盘报20.57元，换手率22.19%，成交量21.11万手，成交额4.33亿元。重仓华绿生物的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞量化阿尔法A。华泰柏瑞量化阿尔法A目前规模为2.03亿元，最新净值1.7639，较上一交易日下跌0.75%，近一年上涨25.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900014568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2594238899","title":"12月25日华绿生物涨5.97%，华泰柏瑞量化阿尔法A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594238899","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594238899?lang=zh_cn&edition=full","pubTime":"2025-12-25 15:37","pubTimestamp":1766648254,"startTime":"0","endTime":"0","summary":"证券之星消息，12月25日华绿生物涨5.97%创60日新高，收盘报18.46元，换手率11.67%，成交量11.11万手，成交额2.06亿元。重仓华绿生物的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞量化阿尔法A。华泰柏瑞量化阿尔法A目前规模为2.03亿元，最新净值1.7591，较上一交易日上涨0.91%，近一年上涨24.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500017186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2586653213","title":"华绿生物：鹿茸菇项目已投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2586653213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586653213?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:38","pubTimestamp":1764214687,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物(300970)11月27日在投资者关系平台上答复投资者关心的问题。投资者提问：领导好，请问公司鹿茸菇项目:江苏泗阳生产基地四厂的原有金针菇生产线进行技术改造，以此布局鹿茸菇品类，该项目为日产约50吨鹿茸菇的生产基地，我们该项目现在已经投产了没？华绿生物回复：您好，该项目已经投产，正处于产能爬坡阶段。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700012799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2582828253","title":"华绿生物：稳步推进新项目建设及鹿茸菇产能扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=2582828253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582828253?lang=zh_cn&edition=full","pubTime":"2025-11-11 08:36","pubTimestamp":1762821374,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物11月10日在投资者关系平台上答复投资者关心的问题。感谢您的关注与建议！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100004782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2580267554","title":"华绿生物：发明专利占专利总数约17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580267554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580267554?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:39","pubTimestamp":1762159149,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物(300970)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，据公开信息显示公司目前拥有专利197项，想请教其中发明专利与实用新型专利的具体数量及占比？2024年新增的“智能金针菇培育室”“蛹虫草菌育种方法”等授权专利，当前在生产场景中的应用转化情况如何，是否已实现产能提升或成本优化的实际成效？华绿生物回复：公司发明专利占专利总数约17%。专利体现研发的成果，有利于生产经营的稳定。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300021803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2580262632","title":"华绿生物：公司产品随行就市，依托现有销售体系即产即销","url":"https://stock-news.laohu8.com/highlight/detail?id=2580262632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580262632?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:27","pubTimestamp":1762158428,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物(300970)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好！公司泗阳鹿茸菇技改项目预计年末满产，该项目达产后预计日产50吨，能否披露其目标市场定位、定价策略及当前订单储备情况？作为差异化珍稀品种，鹿茸菇的毛利率水平是否优于现有主力产品，有望为公司带来多少增量业绩贡献？华绿生物回复：您好，公司产品随行就市，依托现有销售体系即产即销。多品种经营有助于提升公司综合竞争实力。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300021204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2580726458","title":"华绿生物：舞茸目前在公司营业收入中占比较少","url":"https://stock-news.laohu8.com/highlight/detail?id=2580726458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580726458?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:00","pubTimestamp":1762156827,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物(300970)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问： 尊敬的董秘您好！公司舞茸产品为行业内独家工厂化生产的食药兼用菌，且已入选“江苏精品”，目前线上线下渠道布局已初步成型。想请教该产品当前的营收占比、复购率及溢价空间如何？未来是否计划推进舞茸功能性成分提取、保健产品开发等深加工业务，进一步打开价值空间？华绿生物回复：您好，舞茸目前在公司营业收入中占比较少，仍处于市场拓展阶段。感谢您的关注及建议！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300018261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970"],"gpt_icon":0},{"id":"2579458973","title":"华绿生物：基地布局基本完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2579458973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579458973?lang=zh_cn&edition=full","pubTime":"2025-10-31 16:09","pubTimestamp":1761898153,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物10月31日在投资者关系平台上答复投资者关心的问题。公司已形成“东南西北中”的基地布局，且产品远销海外，想请教未来在次一线区域及海外市场的拓展是否有明确推进计划？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100032132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2578993357","title":"华绿生物：公司高度重视投资者信心与市场表现的反差","url":"https://stock-news.laohu8.com/highlight/detail?id=2578993357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578993357?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:48","pubTimestamp":1761641303,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物10月28日在投资者关系平台上答复投资者关心的问题。公司是否关注到这一情况，后续有无提升投资者信心的具体举措？公司高度重视投资者信心与市场表现的反差，股价波动受多种因素影响。为提升投资者信心，公司将通过加强信息披露、举办业绩说明会、深化与市场沟通等方式，更积极地传递公司价值与发展进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800029299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0},{"id":"2578570933","title":"华绿生物：暂未将菌菇辣条等休闲快消食品纳入产品体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2578570933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578570933?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:45","pubTimestamp":1761641122,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物10月28日在投资者关系平台上答复投资者关心的问题。公司暂未将菌菇辣条等休闲快消食品纳入产品体系。公司始终关注市场趋势，并对包括即食产品在内的各种业务可能性进行持续研究和跟踪评估。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800029204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970","BK0227"],"gpt_icon":0},{"id":"2578525729","title":"华绿生物（300970）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578525729","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578525729?lang=zh_cn&edition=full","pubTime":"2025-10-25 06:10","pubTimestamp":1761343858,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华绿生物发布2025年三季报。截至本报告期末，公司营业总收入8.68亿元，同比上升17.98%，归母净利润1633.35万元，同比上升146.55%。按单季度数据看，第三季度营业总收入3.69亿元，同比上升35.24%，第三季度归母净利润7002.82万元，同比上升619.37%。本报告期华绿生物盈利能力上升，毛利率同比增幅78.46%，净利率同比增幅141.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300970"],"gpt_icon":0},{"id":"2577593517","title":"华绿生物：公司产品目前以鲜品销售为主，暂未扩展加工产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2577593517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577593517?lang=zh_cn&edition=full","pubTime":"2025-10-24 16:09","pubTimestamp":1761293349,"startTime":"0","endTime":"0","summary":"证券之星消息，华绿生物10月24日在投资者关系平台上答复投资者关心的问题。想请教，贵司目前对舞茸的开发是否仅停留在食材层面？考虑到医药级菌类产品的市场潜力，未来是否有计划从“食材种植”向“功能性原料供应”延伸，比如为保健品或医药企业提供符合标准的舞茸提取物，以此拓展业务边界？公司产品目前以鲜品销售为主，暂未扩展加工产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400027474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0227","300970"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770500780486,"stockEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.1873},{"period":"3month","weight":0.3219},{"period":"6month","weight":0.4834},{"period":"1year","weight":0.9126},{"period":"ytd","weight":0.1312}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏华绿生物科技集团股份有限公司","boardCode":"AI0001","boardName":"农业","stockholders":"10290人(较上一季度减少9.42%)","perCapita":"9245股","listingDate":"2021-04-12","address":"江苏省宿迁市泗阳县绿都大道88号","registeredCapital":"12260万元","survey":"　　江苏华绿生物科技集团股份有限公司的主营业务是食用菌的研发、工厂化种植及销售。公司的主要产品是包括金针菇、真姬菇（含白玉菇、蟹味菇）、舞茸（灰树花）等鲜品食用菌。","listedPrice":44.77},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华绿生物(300970)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华绿生物(300970)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华绿生物,300970,华绿生物股票,华绿生物股票老虎,华绿生物股票老虎国际,华绿生物行情,华绿生物股票行情,华绿生物股价,华绿生物股市,华绿生物股票价格,华绿生物股票交易,华绿生物股票购买,华绿生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华绿生物(300970)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华绿生物(300970)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}